enarodustat

Small moleculeexperimental

Clinical trial activity

11 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
5
Phase 3
4
Phase 4
2

Earliest trial started Feb 22, 2002 (NCT06720233)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12
Mol. weight
340.34 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • jtz-951
  • jtz-951

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07079579Phase 4Aug 31, 2025Shenzhen Salubris Pharmaceuticals Co., Ltd.
NCT06725810Phase 4Dec 1, 2024Fudan University
NCT06737081Phase 2Sep 14, 2024Jiao Tong University, Shenzhen Salubris Pharmaceuticals Co., Ltd.
NCT06720025Phase 3Sep 19, 2023Shenzhen Salubris Pharmaceuticals Co., Ltd., Sun Yat-Sen University
NCT06016036Phase 3Dec 8, 2020Shantou University, Shenzhen Salubris Pharmaceuticals Co., Ltd.
NCT04027517Phase 3Jan 15, 2019JW Pharmaceutical
NCT02805244Phase 1Jun 1, 2016Akros
NCT02581124Phase 1Oct 1, 2015Akros
NCT01978587Phase 1Oct 1, 2013Akros
NCT01971164Phase 1May 1, 2013Akros
NCT06720233Phase 3Feb 22, 2002Shenzhen Salubris Pharmaceuticals Co., Ltd., Sun Yat-Sen University
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shenzhen Salubris Pharmaceuticals Co., Ltd.For profit5532002
AkrosFor profit4412013
Sun Yat-Sen UniversityAcademic/Hospital2012002
Fudan UniversityAcademic/Hospital1112024
Jiao Tong UniversityAcademic/Hospital1012024
JW PharmaceuticalFor profit1112019
Shantou UniversityAcademic/Hospital1012020
7 organizations
Page 1 / 1